New hope for EoE patients: expanded access to APT-1011

NCT ID NCT05095116

NO_LONGER_AVAILABLE Disease control Sponsor: Ellodi Pharmaceuticals, LP Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times

Summary

This program provides early access to APT-1011, a swallowed steroid tablet, for people aged 12 and older with eosinophilic esophagitis (EoE) who cannot join other studies or have not responded to available treatments. The goal is to offer a potential treatment option until the drug becomes commercially available. Participants will receive the study drug and be monitored regularly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Arkansas Gastroenterology

North Little Rock, Arkansas, 72117, United States
Bernstein Clinical Research Center, LLC

Cincinnati, Ohio, 45236, United States
Boston Specialists

Boston, Massachusetts, 02111, United States
Bozeman Health Clinical Research

Bozeman, Montana, 59715, United States
Carolina Research

Greenville, North Carolina, 27834, United States
Clinical Research Institute of Michigan LLC

Chesterfield, Michigan, 48047, United States
Clinical Research Professionals

Chesterfield, Missouri, 63005, United States
Clinical and Translational Research Center (CTRC)

Chapel Hill, North Carolina, 27599, United States
Del Sol Research Management LLC

Tucson, Arizona, 85715, United States
Endoscopic Research, Inc.

Orlando, Florida, 32803, United States
FOMAT Medical Research

Glendale, California, 91204, United States
GI Alliance

Garland, Texas, 75044, United States
Gastro Center of Maryland

Columbia, Maryland, 21045, United States
Gastro Health Research

Cincinnati, Ohio, 45219, United States
Great Lakes Gastroenterology

Mentor, Ohio, 44060, United States
Henry Ford Health System

Novi, Michigan, 48377, United States
MGG Group Co., Inc.

Chevy Chase, Maryland, 20815, United States
MNGI Digestive Health, P.A.

Minneapolis, Minnesota, 55413, United States
Medical Associates Research Group

San Diego, California, 92123, United States
Medical Research Center of Connecticut

Hamden, Connecticut, 06518-3694, United States
Minnesota Gastroenterology PA Plymouth Endoscopy Center Clinic

Plymouth, Minnesota, 55446, United States
Nature Coast Clinical Research

Inverness, Florida, 34452, United States
Northshore Gastroenterology Research LLC

Westlake, Ohio, 44145, United States
Nuvance Health Medical Practice Ct, Inc.

Danbury, Connecticut, 06810, United States
Peak Gastroenterology Associates

Colorado Springs, Colorado, 80907, United States
Rapid City Medical Center LLP

Rapid City, South Dakota, 57701, United States
Regional Gastroenterology Associates of Lancaster, Ltd.

Wyomissing, Pennsylvania, 19610, United States
Summit Clinical Research

Athens, Georgia, 30607, United States
United Medical Doctors

Murrieta, California, 92563, United States
University of Iowa Hospitals and Clinics

Iowa City, Iowa, 52242, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
Ventura County Gastroenterology Medical Group Camarillo

Camarillo, California, 93012, United States
Vital Prospects Clinical Research Institute, P.C.

Tulsa, Oklahoma, 74136, United States
West Michigan Clinical Research Center

Wyoming, Michigan, 49519, United States
Western States Clinical Research Inc

Wheat Ridge, Colorado, 80033, United States

Conditions

Explore the condition pages connected to this study.

EOSINOPHILIC ESOPHAGITIS